Five-year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.

Catheter Cardiovasc Interv · 2022 · PMC9544452 · PMID 34173699

Europe PMC DOI

hedged sentence

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

showed a trendp = 0.11not close (p > 0.1)

The BVS showed a trend toward a wider external elastic membrane area (12.86 ± 3.25 mm 2 ) when compared with EES/BES (11.58 ± 3.69 mm 2 ; p = 0.11).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.